• News

SEURO project is looking for volunteers to test digital technologies for self-managing health

Two older people in the foreground laughing and talking. A man in the background smiles, keeping his hands on their shoulders.

SEURO project partners will test a digital tool to improve health self-management for people with multiple diseases in Europe.

SEURO project’s staff is recruiting 720 participants from Belgium, Ireland, and Sweden, to test its new health and well-being system.

SEURO project aims at evaluating key factors necessary to prepare all European regions to successfully implement innovative, people-centric digital health solutions for multiple disease management. To achieve this, SEURO researchers developed ProACT, a people-driven platform to support health self-management.

The trial

The tested digital tool is directed to people with multiple diseases and the trial will last 6 months. Candidates should be over 65 years old and have two or more chronic diseases. The chronic conditions included in this study are diabetes, chronic obstructive pulmonary disease (emphysema and chronic bronchitis), chronic asthma, heart failure, and chronic heart disease (angina, high blood pressure, atherosclerosis, and arrhythmia).

The goal of SEURO’s researchers is to test a digital technology that could help participants to have more control over their health, providing researchers with important feedback on the tested tool. No technical skills are required, as SEURO staff will be available to help anytime, and the entire care network around the older person can participate over this trial. More details are available on the project’s official website.

Why should I get involved?

First, participation is completely voluntary, and participants can choose to stop their collaboration at any given moment. Moreover, as explained by Dr. Julia Doyle (Dundalk Institute of Technology) in an interview on Dublin People: “By participating in the SEURO trial, you will be making a significant contribution to this very exciting and much-needed area of research and if selected to test the technology, you may experience improvements in the management of your conditions.”